The authors wish to apologize to readers for an incorrect element in Table [1](#Tab1){ref-type="table"} and Figure [1](#Fig1){ref-type="fig"} in the original article \[[@CR1]\]. The correct files have been included in this erratum. We also wish to thank Sara Heesterbeek for alerting us to our error.Table 1Interventions mentioned in research priorities identified by James Lind Alliance Priority Setting Partnerships, and among registered trials, 2003-2012Type of interventionJLA patient-clinician Priority Setting PartnershipsRegistered non-commercial trialsRegistered commercial trialsPercentages (numbers) of interventions out of a total of 126 interventions mentionedPercentage (numbers) of interventions out of a total of 1069 interventions mentionedPercentage (numbers) of interventions out of a total of 798 interventions mentionedDrugs, vaccines and biologicals18 (23)37 (397)86 (689)Radiotherapy, surgery and perioperative, devices, and diagnostic23 (29)31 (332)11 (89)Education and training, service delivery, psychological therapy, physical therapies, exercise, complementary therapies, social care, mixed or complex, diet, other59 (74)32 (340)3 (20)Fig. 1Interventions mentioned in commercial trials, non-commercial trials and research priorities identified by James Lind Alliance Priority Setting Partnerships, 2003-2012
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